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Gastroduodenal refluxate found in the upper aerodigestive tract is not clinically uncommon.We recently demonstrated
the neoplastic potential of gastroduodenal fluids (GDF) on hypopharyngealmucosa, via NF-κB, using in vitro and in vivo
models. Here we will explore the in vivo effect of GDF on laryngeal mucosa (LM) to induce early preneoplastic lesions
related to NF-κB activation, along with deregulation of specific microRNA (miRNA) markers previously linked to
laryngeal cancer. We used histological, immunohistochemical, automated quantitative analysis and quantitative
polymerase chain reaction to examine LM from 35 C57Bl/6J mice previously treated with topical GDF against
corresponding controls (4 experimental and 3 control groups; 5mice/group). Our analysis showed that GDF produced
early preneoplastic lesions in treated LM related to NF-κB activation. LM treated by acid and bile combination
demonstrated significantly higher expression of the analyzed cell proliferationmarkers (Ki67, CK14, Np63), oncogenic
p-STAT3, and changes of cell adhesion molecules (E-cadherin, -catenin) versus untreated LM or LM exposed to
acid alone (P b .0005). Furthermore, acidic bile but not neutral bile appeared to accelerate the expression of “oncomirs”
miR-21, miR-155, and miR-192 (acidic bile versus neutral bile, P b .0001), while reducing tumor suppressor miR-375
(acidic bile versus neutral bile, P= .0137), previously linked to NF-κB and laryngeal cancer. Finally, acidic bile induced
reduction of miR-34a, miR-375, andmiR-451a, exhibiting an inverse correlation with NF-κB activation. SIGNIFICANCE:
Bile in combinationwith acid has a selective tumorigenic effect on LM, inducing deregulation of “oncomirs” and tumor
suppressor miRNAs, produced by NF-κB activation with molecular and early histopathological alterations linked to
neoplastic transformation. Systematic acid suppression may in part convey a protective role.
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Gastroesophageal reflux disease (GERD) is estimated to affect 19
million Americans, whereas its prevalence has significantly increased in
the United States over the last two decades, ranging from 18.1% to
27.8% [1,2]. Furthermore, there is growing evidence that approxi-
mately 50% to 80% of patients with GERD present with mixed gastric
and duodenal bile acids in their refluxate [3,4], whereas the clinical
prevalence and magnitude of gastroduodenal reflux may be actually
greater than it was previously reported, according to Covington et al [5].
There is further evidence that extraesophageal bile acids found in the
upper aerodigestive tracts of patients are now linked to advanced
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growing association of larynx cancer and reflux disease [7–9].
Constitutive activation of NF-κB has been observed in various cancers,
including head and neck squamous cell carcinomas (HNSCCs) [10,11].
Its downstream oncogenic pathways that are related to combined or
independent effects of inflammatory risk factorsmay also be crucial for the
development of malignant transformation in laryngeal mucosa (LM).
AlteredmicroRNA (miRNA) profiles induced by elevatedNF-κB activity
play a key role in molecular dysfunctions linking inflammation to cancer
[12]. We recently demonstrated the role of gastroduodenal fluid (GDF)
in hypopharyngeal neoplasia through activation of the NF-κB pathway
using an in vitro model of human hypopharyngeal normal keratinocytes
[13]. Moreover, our recent findings from a novel in vivo model of
C57Bl/6J mice [14] links NF-κB activation to early premalignant
hypopharyngeal mucosal (HM) lesions, in a short period of 45 days when
topically treated with GDFs, and particularly with acidic bile or
deoxycholic acid (DCA), one of the active components of bile. In that
study, we identified underlying molecular alterations supporting the
process of malignant transformation, including markers of increased cell
proliferation (Ki67, CK14, ΔNp63), epithelial mesenchymal transition
(EMT) by changes of cell adhesion molecules E-cadherin and β-catenin,
and activation of STAT3 oncogene.
Similar to NF-κB transcriptional factors, miRNA molecules have
been considered important key factors between inflammation and
cancer [15]. Specifically, miRNA is a class of endogenous, small,
noncoding RNAs that modulate gene expression by causing target
mRNA degradation or inhibiting their translation [12,16]. Although
miRNA short molecules are involved in complex pathways, specific
miRNA signatures have been identified in a number of cancers,
including laryngopharyngeal cancer [12,17,18]. Specifically, deregula-
tion of “oncomirs” miR-21, -155, and -192 and tumor suppressors
miR-375, -451a and -34a has been reported in laryngeal cancer
[19–24]. Interestingly, an association was previously found between
NF-κB activation and upregulation of oncogenic miR-21 and/or
downregulation of tumor suppressors miR-34a and miR-451a [25,26],
which are also deregulated in HNSCCs [12,19–22,24,27]. Moreover,
GDF has been shown to stimulate the upregulation of specific
biomarkers, like miR-192, in epithelial cells [28]. We hypothesize that
the in vivo effect of GDF may deregulate oncogenic miRNAs in treated
LM exhibiting significant NF-κB activation and histological and
molecular alterations, supporting neoplastic transformation.
The hypopharynx and larynx are anatomically located at the junction
of upper aero- and digestive tracts. Although the larynx is in close
proximity to the hypopharynx, there is reason to suggest oncologic
differences by quoted overall 5-year survivals. Supraglottic laryngeal
cancer carries a 5-year survival of 43% versus hypopharyngeal cancer of
20% [29]. Furthermore, the supraglottic larynx differs from the glottic
larynx (true vocal cords) in at least two ways: 1) the supraglottis consists
of nonkeratinizing squamous epithelium and the vocal cords of stratified
keratinizing squamous epithelium and 2) overall 5-year survivals of 43%
versus 80%, respectively [29]. In this study, we will therefore limit our
experimental inquiry to supraglottic rather than glottic tissue, the latter at
greater risk to inhalant rather than digestive exposure.
Materials and Methods
In Vivo Mouse Model
We previously established an animal model to explore the effect
of GDF in hypopharyngeal carcinogenesis via NF-κB activation [14].Similar to our prior in vivomurine model, we established a mouse model
using wild-type C57Bl/6J to study the effect of GDF on LM in vivo. As in
that study, we used 35 wild-type C57B1/6J mice, shared in 4
experimental and 3 control groups (5 mice/group). Experimental fluids
included 1) acidic bile salts, containing 10mMof conjugated bile salts in a
mixture (GCA+TCA+GCDCA+TCDCA+GDCA+TDCA; Sigma,
St. Louis, MO, and Calbiochem, SanDiego, CA) at molar concentration
(20:3:15:3:6:1) as previously described [30], in buffered saline, brought to
a pH of 3 with 1 M HCI (using a pH meter) and 2) neutral bile salts,
containing the same bile saltmixture in buffered saline at pH7.0. 3)DCA
10 mM, in buffered saline at pH 7.0 (Alfa Aesar, MA, USA) and
4) unconjugated chenodeoxycholic acid or CDCA 10 mM, in buffered
saline at pH 7.0 (Sigma Aldrich, MO, USA). Control fluids consisted
of 1) acid alone, consisting of buffered saline brought to pH 1.5 with 1
M HCI and considered as positive control; 2) highly concentrated
glucose used as negative control (33 mM in buffered saline, pH 7.0);
and 3) untreated control used as reference control.
pH 3.0 was selected because prior studies of 24-hour ambulatory pH
monitoring in the pharynx of patients revealed frequent drops in pH to
levels lower than pH 4.0 (excluding the influence of uncommon
heterotopic gastric mucosa) [31]. We have used mixtures of conjugated
bile acids at molar concentrations previously reported in symptomatic
GERD patients [3]. In the case of DCA and CDCA, 10 mM test
solutions were used in accordance with pharmacologic but nontoxic
concentrations described in studies on rabbit esophagus [32], under-
standing that physiologic concentrations used in an in vivomodel may be
otherwise less effective.
We used a plastic feeding tube to administer a small quantity
(150-200 μl) of experimental or control fluids to the larynx, twice a day
for 45 days. At the end of experimental procedures, we harvested
supraglottic laryngeal tissue from euthanized animals. These samples
were obtained collectively from epiglottis, aryepiglotic folds, and false
vocal cords from each animal. Four of five collective specimens were
immersed immediately in 10% neutral buffered formalin and
transported to the Pathology Department for paraffin embedding,
whereas a fifth collective specimen was immersed in RNA stabilization
solution (RNAlater, Life Technologies) and kept in −20°C for
molecular analysis.
Histological Analysis
Tissue sections of 3 to 4 μm from formalin-fixed and paraffin-
embedded tissue specimens were stained with hematoxylin and eosin
(H&E) for histological analysis. We examined H&E-stained slides by
light microscopy, whereas images were captured and analyzed by Aperio
CS2, Image Scope software (Leica Microsystems, Buffalo Grove, IL).
Histopathological alterations were assessed according to previous criteria
(WHO, Ljubljanska) [33,34] and laboratory mouse histology [35].
Normal mouse LM was characterized by intermediate epithelium (low
squamoid epithelium) and was considered as controls. Hyperplasia was
characterized by thickened intermediate epithelium. Abnormal hyper-
plasia was characterized by thickened intermediate epithelium with
expansion of basal cells into the suprabasal layer without cytologic
atypia, considered by some as a precursor for malignant transformation
[33,34]. Thickness of epithelium was measured using the Aperio CS2,
Image Scope software (LeicaMicrosystems).Mild-dysplastic epithelium
was characterized by architectural disorder and/or hyperchromatic or
pleomorphic basal cells expanded into the stratum spinosum but
confined to the lower one third of the epithelium. Moderate dysplasia
was demonstrated by nuclear hyperchromatism with a high degree of
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nuclear to cytoplasm ratios expanding into the middle third of the
epithelium. Severe-dysplastic epithelium was characterized by marked
full-thickness cytological changes including abnormal mitoses with loss
of stratification. (All tissue specimens were grossly examined to exclude
those with signs of local treatment toxicity, such as hemorrhagic lesions,
ulceration, or inflammation).
Immunohistochemical Automated Quantified Analysis
We performed immunohistochemical analysis and automated
quantified analysis (AQUA) to analyze the protein expression levels of
p-NF-κB (p65 S536), Ki67, ΔNp63, CK14, E-cadherin, β-catenin,
and p-STAT3 (Tyr705) in treated LM relative to untreated LM, as
we previously described [14] (Supplementary methods).
Images of LM tissue sections were captured and analyzed using
PM-2000 image workstation and HistoRX software. For each whole
tissue section, areas of LM were selected, whereas compartments of
submucosa were excluded, using AQUA software. The signal intensity
of target antigen was acquired using DyLight 488 (similar to fluorescein
isothiocyanate) signal or DYLight 549 (similar to Cy3) signal relative to
tumor mask. The signal intensity of nuclei was acquired using DAPI
signal. Maturing squamous cells that were losing their nuclei were
counted as negative cells. AQUA scores within nucleus and cytoplasm
(or membrane) were calculated by dividing the signal intensity by the
area of the specified compartment.
miRNA Analysis
We performed miRNA analysis in murine GDF-treated LM and
untreated controls to determine expression levels of miR-21, -155, -192,
-375, -451a, and -34a previously characterized as laryngeal or
hypopharyngeal cancer-related miRNAs [19–24,27]. We used miScript
II RT kit (Qiagen, Louisville, KY) to perform reverse transcription
synthesis of miRNAs from total RNA according to the manufacturer’s
instructions. Total RNA was isolated from representative murine
laryngeal tissue specimens of GDF-treated groups (acidic bile, neutral
bile, DCA, and CDCA) and of a normal untreated group using RNeasy
mini kit (Qiagen). RNA quality and concentration ratios by absorption
at 260 nmwere determined using aNanoDrop 1000 spectrophotometer
(Thermo Scientific). The quantification of specific miRNAmarkers was
performed by quantitative polymerase chain reaction (qPCR) analysis
(Bio-Rad real-time thermal cycler CFX96TM) using specific primers for
target miRNAs of mouse genome (miScript Primer Assay, Qiagen) and
normalization control small RNA RNU6B (snRNA RNU6-2; Qiagen)
(Table 1), and miScript SYBR Green PCR Kit (Qiagen). QuantitativeTable 1. Targets for Mouse Mature miRNA and RNU6 Small RNA Control, Analyzed by
Real-Time qPCR, in Murine GDF-Treated LM and Untreated Control
miRNA (Mouse) Target Mature miRNA
miR-21 mmu-miR-21a-5p, MI0000569
miR-192 mmu-miR-192-5p, MI0000551
miR-155 mmu-miR-155-5p, MI0000177
miR-375 mmu-miR-375-5p, MI0000792
miR-34a mmu-miR-34a-5p, MI0000584
miR-451a mmu-miR-451a, MI0001730
Small RNA Control
RNU6-6P RNA, U6
small nuclear 6, pseudogene
Hs_RNU6-2_11real-time PCR assays were performed in 96-well plates, and each sample
was assayed in triplicate. These data were analyzed by CFX96TM
software (Bio-Rad, Hercules, CA). Relative miRNA expression of
experimental (acidic bile–, neutral bile–, DCA-, and CDCA-treated
LM) to normal (untreated LM) was estimated by CFX96TM (Bio-Rad)
software for each specific miRNA marker.
Statistical Analysis
We performed a statistical analysis using GraphPad Prism 6 software.
Data obtained from AQUA and real-time qPCR analysis were calculated
and analyzed byHistoRX (HistoRX Inc., Branford, CT) andCFX96TM
(Bio-Rad) software, respectively. To obtain differences of AQUA scores,
thickness of mucosa, or miRNA expression values between experimental
and control groups, we performed comparisons using one-way analysis of
variance (ANOVA), nonparametric Kruskal-Wallis test, and
Holm-Sidak’s or Dunn’s multiple-comparison test (significance was
defined as P values b .05). The correlation coefficient (r) between protein
and miRNA expression levels of different groups was estimated by
Pearson correlation (significance P values b .05).
Results
In Vivo GDF Induced Early Preneoplastic Alterations in
Murine LM
The chronic exposure of GDF on murine LM, in vivo, induces early
preneoplastic lesions [33,34,36–38] (Figure 1). Microscopic examina-
tion of H&E-stained and GDF-treated LM reveals hyperplastic and
dysplastic changes compared with normal LM. In contrast, LM derived
from mice exposed to acid alone or concentrated glucose produces no
histologic change (Figure 1A). Specifically, hyperplasia of intermediate
epithelium is identified in CDCA-treated LM (Figure 1B). Moreover,
abnormal hyperplasia of intermediate epithelium and mild dysplastic
changes are identified in neutral bile–treated LM (Figure 1C), whereas
moderate dysplastic lesions are identified in acidic bile– and
DCA-treated LM (Figure 1D). Neutral bile–, acidic bile–, and
DCA-treated LM exhibits significant increase in thickness compared
with normal untreated LM (2.1-3.8× normal) or to LM exposed to acid
alone (2.9-5.1× acid) (P b .05; by Kruskal-Wallis) (Figure 1E). The
graph in Figure 1F demonstrates the percentages of mice exhibiting
histopathological alteration by treatment category. There are no
histological signs of acute local treatment toxicity.
In Vivo GDF Induced NF-κB Activation and Correlations
with Preneoplastic Alterations in LM
The microscopic examination of GDF-treated LM, and particularly
at sites of hyperplastic or dysplastic lesions, reveals a significant
activation of NF-κB (p65 S536) throughout its thickness (Figure 2)
relative to normal (untreated LM) (Figure 2A). We find that neutral
bile, acidic bile mixtures or bile components DCA or CDCA induce
elevated NF-κB activation, indicated by an intense p-NF-κB nuclear
staining of cells in basal extending to suprabasal layers (Figure 2B). In
contrast, the untreated LM did not exhibit NF-κB activation by virtue
of negative nuclear NF-κB (p65 S536) staining. Acid alone induces less
intense and less extensive NF-κB activation compared with acidic bile
(intense cytoplasmic p-NF-κB staining and few sporadic cells with
nuclear p-NF-κB staining limited to the basal layer of LM). Finally, the
glucose-treated LM exhibits low levels of NF-κB activation in few and
sporadic cells, a pattern considered negative for NF-κB activation.
The immunofluorescence (IF) and AQUA analysis for NF-κB, cell
proliferation markers, cell adhesion molecules, and STAT3 in
Figure 1. GDF-induced preneoplastic lesions in murine LM of C57BL/6J mice (H&E staining). (A) Normal LM: intermediate (low squamoid
nonkeratinizing) epithelium. (B) Hyperplastic LM: thickened intermediate epithelium. (C) Abnormal hyperplastic/mildly dysplastic LM:
thickened intermediate epithelium, hyperchromatic or pleomorphic basal cells expanding in the stratum spinosum. (D) Moderately
dysplastic LM: high degree of basal layer expansion, nuclear hyperchromatism with increase of nuclear to cytoplasmic ratios, and loss of
cell polarity. (E) Columns of graph created by GraphPad software correspond to mean thickness of LM under different treatments
allowing comparison to control (*P b .05; **P b .005 ANOVA, Kruskal-Wallis test; GraphPad Prism 6.0). (F) Graph demonstrating the
percentage of C57Bl/6J mice exhibiting histological alterations in LM.
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following results:
A. In Vivo GDF Induces NF-κB and ΔNp63 Activation
The IF staining of p-NF-κB shown in Figure 3A-a confirms our results from
chromogenic staining (Figure 2). Acidic bile–treated LM shows an intense and
expanded nuclear p-NF-κB (p65 S536) (green) andΔNp63 (red) staining in basal/parabasal and/or suprabasal layers, particularly at preneoplastic sites. Neutral
bile–, DCA-, and CDCA-treated LM demonstrates nuclear p-NF-κB staining of
basal/parabasal cells, particularly at hyperplastic or dysplastic sites, but with
ΔNp63 staining expanding less in thickness than acidic bile–treated LM. Acid
alone produces nuclear p-NF-κB staining in sporadic cells of basal/parabasal layers
and ΔNp63 expression limited to the basal layer. In contrast, normal unteated LM
exhibits a weak cytoplasmic p-NF-κB and nuclear ΔNp63 staining limited to the
Figure 2. GDF-induced NF-κB activation in murine LM. (A) Immunohistochemical analysis for p-NF-κB (p65 S536) (from left to right):
control (normal) untreated LM, cytoplasmic staining; glucose-treated LM, weak cytoplasmic or nuclear staining sporadically of few basal
cells; acid alone–treated LM, nuclear or cytoplasmic staining mainly of cells of basal layer and weak cytoplasmic staining of suprabasal
layers; hyperplastic/dysplastic neutral bile–, acidic bile–, DCA-, and CDCA-treated LM, intense nuclear and cytoplasmic staining of cells of
basal and parabasal/suprabasal layers. (B) Image analysis algorithm(s) (red, nuclear positive staining of p-NF-κB; orange, intense positive
cytoplasmic staining of p-NF-κB; yellow, weak cytoplasmic staining of p-NF-κB; blue, negative p-NF-κB staining). [Images were captured
using Aperio CS2 and analyzed by Image Scope software (LeicaMicrosystems), which generated algorithm(s) illustrating themucosal and
cellular compartments demonstrating p-NF-κB staining].
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untreated LM.
AQUA analysis reveals significantly higher nuclear p-NF-κB andΔNp63means of
AQUA scores (AQUA-means) in the acidic bile–treated LM compared with
untreated-LM (P b .0005 and P b .005, respectively) or compared with LM
exposed to acid alone (P b .005), followed by neutral bile and CDCA compared
with untreated LM (P b .05) (Figure 3B-a) (by Kruskal-Wallis).
B. In Vivo GDF Induces Increased Ki67 and Reduction of E-Cadherin
Acidic bile– and neutral bile–treated LM exhibits an expansion of Ki67 (green)
expression, particularly at parabasal/suprabasal layers at preneoplastic sites,
compared with normal untreated LM, acid alone–treated LM, or glucose-treated
LM (Figure 3A-b). On the contrary, the same acidic bile– and neutral bile–treated
LMs exhibit less intense E-cadherin (red) staining compared with normal untreated
LM, acid alone–treated LM, or hyperplastic CDCA-treated LM exhibiting an
intense E-cadherin staining within its entire thickness. Both DCA- and
CDCA-treated LMs show Ki67 staining located at basal and/or parabasal layers.
AQUA analysis reveals significantly higher Ki67 AQUA-mean in the acidic bile–
treated LM relative to normal untreated LM (P b .05) or compared with LM exposed
to acid alone (P b .0005) (Figure 3B-b). AQUA-mean of Ki67 in neutral bile–, DCA-,
and CDCA-treated LM is significantly higher compared with acid alone (P b .005,
P b .005, and P b .05, respectively). Moreover, AQUA-mean of E-cadherin
demonstrates significantly lower levels in the acidic bile– and neutral bile–treated
LM versus untreated LM (P b .05) (Figure 3B-b) (by Kruskal-Wallis).
C. In Vivo GDF Induces Increased CK14 and β-Catenin Levels
We demonstrate in Figure 3A-c an extended CK14 (green) expression in the entire
thickness of GDF-treated LM, and particularly in dysplastic acidic bile–treated LM,compared with normal untreated LM or acid alone–treated LM, in which CK14 is
limited to the basal layer. Moreover, the same dysplastic acidic bile–treated LM and
the hyperplastic CDCA-treated LM demonstrate an intense staining of β-catenin
(red) compared with normal untreated LM or LM exposed to glucose or acid alone.
AQUA analysis reveals a significant increase of CK14 and β-catenin AQUA-means
in the acidic bile–treated LM relative to untreated LM (P b .05) or compared with
LM exposed to acid alone (P b .005) (Figure 3B-c). We also show higher
AQUA-mean of β-catenin in CDCA-treated LM versus untreated LM (P b .05)
(Figure 3B-c) (by Kruskal-Wallis).
D. In Vivo GDF Induces STAT3 Activation
We demonstrate in Figure 3A-d an intense p-STAT3 (Tyr705) (green) nuclear staining
in the GDF-treated LM and particularly in acidic bile–treated preneoplastic lesions. In
contrast, the normal untreated LM shows no STAT3 activation, similar to LMexposed
to glucose or acid alone. Neutral bile, DCA, and CDCA produces a weak p-STAT3
nuclear staining.
AQUA analysis reveals significantly higher nuclear p-STAT3 AQUA-mean in the acidic
bile–treated LM compared with untreated LM (P b .05) (Figure 3B-d) (Kruskal-Wallis).
Correlations among p-NF-κB, Ki67, ΔNp63, CK14, β-Catenin,
and E-Cadherin Molecular Alterations Induced by GDF
Pearson analysis reveals significant positive relationships among the
underlying molecular alterations of GDF-treated LM (GraphPad
Prism 6.0). Figure 4 demonstrates positive Pearson correlations between
the expression levels (AQUA-means) of activatedNF-κB andΔNp63 (r =
0.92418168, P = .0029), p-STAT3 (r = 0.950038572, P = .0010), or
Figure 3. GDF induces molecular alterations underlying preneoplastic alterations of murine LM related to NF-κB activation, cell
proliferation (indicated by increased ΔNp63, Ki67, and CK14 levels), EMT (supported by changes of cell-cell adhesion molecules
E-cadherin and β-catenin), and STAT3 activation. IF staining (A) and AQUA (B) for (a) p-NF-κB (p65 S536) (green) and ΔNp63 (red); (b) Ki67
(green) and E-cadherin (red); (c) CK14 (green) and -catenin (red); and (d) p-STAT3 (Tyr705) (green) (from left to right): Normal untreated
LM, glucose- and acid alone–treated LM; and hyperplastic/dysplastic neutral bile–, acidic bile–, DCA-, and CDCA-treated LM derived from
C57Bl/6J mice. DAPI (blue) was used for nuclear staining (DyLight®488 for green and DyLight®549 for red). The box plots represent the
mean ranks. The upper line indicates the highest value, the lower line the lowest value, and the middle line the mean of AQUA normalized
quantities of each variable. Statistically significant difference between AQUA score means is indicated for GDF-treated LM versus normal
untreated LM (right) and GDF- versus acid-treated LM (left) (*P b .05; **P b .005; ***P b .0005; one-way ANOVA, Kruskal-Wallis and
Dunn’s multiple comparison tests; GraphPad Prism 6.0).
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as between ΔNp63 and CK14 (r = 0.905020427, P = .0051) or
p-STAT3 (r = 0.900191778, P = .0057) (Figure 4A-c), and between
p-STAT3 and β-catenin (r = 0.811874255,P = .0266) (Figure 4A-d), and
an inverse correlation between E-cadherin and β-catenin in GDF-treated
LM (r = −0.511020934), particularly with respect to acidic bile–treated
LM versus untreated LM (r = −1, P b .0001) (Figure 4B).Acidic Bile Induced Deregulation of Cancer-Related miRNAs
in LM
The in vivo effect of acid and bile combination on murine LM
selectively induces deregulation of cancer-related miR-21, -155, -192,
and -375 (Figure 5). Our miRNA analysis, by real-time qPCR, reveals a
significant overexpression (upregulation) of “oncomirs” miR-21, -192,
and -155 (Figure 5A) and a significant reduction (downregulation) of
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compared with untreated LM (P b .0001). In contrast, we observe an
inverted phenotype for the analyzed miRNA markers in neutral bile–
and DCA-treated LM, showing low or reduced levels of “oncomirs,”
particularly of miR-155 in neutral bile–treated LM compared with
untreated LM (P = .0123), as well as increased levels of tumor
suppressor miR-375 compared with untreated LM (P = .0018, and
P b .0001, respectively). In the same way, the CDCA-treated LM
produces an inverted phenotype for the analyzed “oncomirs,” showing
a significant reduction of miR-155 compared with untreated LM
(P = .0313). However, we show that CDCA results in a significant
reduction of tumor suppressor miR-375 in treated LM compared
with untreated LM (P b .0001), similar to acidic bile. Moreover, our
analysis shows that GDF, and particularly acidic bile, induces a
significant reduction of tumor suppressor miR-34a and -451a in
treated LM compared with untreated LM (P b .0001) (Figure 5B)
(by one-way ANOVA; Holm-Sidak's multiple-comparisons test).
Our statistical analysis reveals that acidic bile induces the most
significant deregulation (upregulation or downregulation) for the
analyzed “oncomirs” and tumor suppressor miRNAmarkers compared
with neutral bile (P b .0001 and P = .0217, respectively), DCA (P =
.0177 and P = .0038, respectively), and CDCA (P = .0020) (Figure 5C)
(by Kruskal-Wallis; Dunn’s multiple-comparisons test).
Correlations among miRNA Deregulations in GDF-Affected
Murine LM and between NF-κB Activation and Oncogenic
miRNA Deregulation in Acidic Bile–Treated Murine LM
Pearson analysis reveals strong linear correlations among “oncomirs”
expression in GDF-treated LM (Figure 6A). Specifically, we identify
a significant positive correlation between miR-21 and -155 (r =Figure 4. Correlation among GDF-induced molecular alterations in tr
between (a) NF-κB and ΔNp63 or p-STAT3, (b) NF-κB and β-catenin
and β-catenin levels in treated LM (P value b .05). (B) Graph demonstra
and E-cadherin in acidic bile–treated LM versus untreated LM (P valu0.997509461) or miR-192 (r = 0.99990467) (Figure 6A-a) and
between miR-155 and miR-192 (r = 0.998075336) (P b .0001)
(Figure 6A-b).
Our analysis also reveals significant relationships between NF-κB
activation and deregulation of oncogenic miRNAmarkers in acidic bile–
treated LM. Specifically, we observe a strongly positive correlation
between NF-κB activation and upregulation of “oncomirs” miR-21,
-155, or -192 (r = 1, P b .0001) (Figure 6B). In contrast, we identify a
strong inverted correlation between NF-κB activation and downregu-
lation of tumor suppressormiR-34a, -451a, and -375 (r = −1,P b .0001)
(Figure 6C-a and b).
Discussion
Although there have been efforts to link the effect of pepsin found in
gastroesophageal refluxate to preneoplastic events in larynx and
pharynx, the conclusions have been at best divergent. Adams favors
the preneoplastic role of combined pepsin and acid [39], whereas
Bock and Johnston defend the effect of nonacidic pepsin [40,41]. On
the other hand, Del Negro in an in vivo rat model describes no
evidence of neoplastic activity with pepsin and acid [42].
We chose to explore these events with respect to bile rather than
pepsin in early neoplasia of laryngeal squamous epithelium. In this
regard, we recently showed the tumorigenic effect of GDF on murine
HM, mediated through the NF-κB–activated pathway, using a novel
model of wild-type C57Bl6J mice [14]. Here we provide evidence
that GDF induces preneoplastic transformation in murine LM related
to and correlated with underlying molecular alterations through
NF-κB activation and miRNA deregulation.
Various studies have proven that ΔNp63 is an oncogene linked to
HNSCCs [43] and predictive of malignant transformation in oraleated LM by Pearson. (A) Diagrams depicting positive correlation
levels, (c) ΔNp63 and CK14 or p-STAT3 levels, and (d) p-STAT3
tes strong inverted phenotype of cell adhesion molecules β-catenin
e b .0001).
Figure 5. In vivo acidic bile induced deregulation of cancer-related miRNAs in murine LM. (A) Upregulation of “oncomirs” miR-21, miR-155,
and miR-192 in acidic bile–treated LM versus untreated LM (by one-way ANOVA). (B) Downregulation of tumor suppressors miR-375, -34a,
and -451a inGDFandparticularly in acidic bile–treatedLMversusuntreatedLM (byone-wayANOVA). (C) Graphs represent thederegulationof
the analyzed “oncomirs” and tumor suppressor miRNAs in each GDF group of treatment. We show a significantly higher upregulation of
“oncomirs” and more intense downregulation of tumor suppressor miRNAs in acidic bile–treated LM compared with LM exposed to neutral
bile/DCA/CDCA (ANOVA, by Kruskal-Wallis). Columns of graphs created by Graph Pad Prism software 6.0 correspond tomiRNAmeans. The
upper line of column indicates the highest measurement (*P b .05; **P b .005; ***P b .0005;****P b .00005).
336 Acidic bile effect in laryngeal neoplasia in vivo Sasaki and Vageli Neoplasia Vol. 18, No. 6, 2016epithelial dysplasia and early stages of laryngeal tumorigenesis [44,45].
Our current data demonstrate that ΔNp63 is a major index of
GDF-induced tumorigenic potential that appears specifically related toFigure 6. Correlation among GDF-induced deregulation of cancer rel
correlation between (a) miR-21, -155, and -192 and (b) between miR-1
correlation between NF-κB activation and “oncomirs” miR-21, -155, and
inducedNF-κBactivation and tumor suppressors (a)miR-34a,miR-375, aacid and bile salt combinations via NF-κB, in agreement with our prior
in vitro data from human hypopharyngeal normal keratinocytes and
in vivo findings from HM [13,14] and with previous studiesated miRNAs and NF-κB activation. Diagrams depicting (A) positive
55 and -192 levels (miRNA levels normalized to RNU6); (B) positive
-192 expression; and (C) an inverse correlation between acidic bile–
nd (b)miR-451a expression in treatedLM (P valueb .0001; byPearson).
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processes of epithelial cells [46].
Increased expression of Ki67 and CK14, cell proliferation markers,
previously identified in human laryngeal hyperplastic or dysplastic
lesions [47,48] is considered to characterize early preneoplastic
alterations of the upper aerodigestive tract [49]. Our data show that
GDF-treated LM exhibits elevated and expanded expression of Ki67
and CK14, particularly at preneoplastic sites affected by acidic bile,
indicating increased cell proliferation rates.
Significant changes in cell-cell adhesion molecules, such as β-catenin
and E-cadherin, are previously linked to oral dysplastic lesions [50] and
are related to malignant transformation of laryngeal tissues [51].
According to our prior in vivo findings, GDF-induced alterations of
β-catenin and E-cadherin are also related to premalignant lesions inHM
[14]. Our current data support an understanding that GDF-induced
alterations of tight cell adhesions in treated LM may lead to a more
mobile and a loosely mesenchymal phenotype previously identified as
precursor to cancer linked to NF-κB activation [50,52]. Our current
in vivo model demonstrates a significant inverted expression between
E-cadherin and β-catenin proteins and between preneoplastic acidic
bile–treated LM and normal untreated LM, supporting an EMT
process, again in agreement with our prior study on HM [17].
Constitutive activation of signal transducers and activators of
transcription, STAT3, has been linked to laryngeal carcinoma [53]
and considered as an early event in head and neck carcinogenesis [54].
Our prior in vitro and in vivo models demonstrated that STAT3
activation linked to acidic bile induced NF-κB and a hypopharyngeal
cancer-related phenotype. Our current model further demonstrates the
acid and bile combination as related to STAT3 activation in LM
compared with normal untreated LM or LM exposed to other stress
factors such as glucose. We also confirm a linear correlation between
STAT3 and NF-κB activation, in accordance with our prior findings in
HM and other studies [14,55].
The selective effect of acidic bile on LM is further reflected by the
significant deregulation of miRNA biomarkers, previously linked to
laryngeal cancer [19–23]. Specifically, acidic bile but not neutral bile,
DCA, or CDCA results in upregulation of “oncomirs”miR-21,-155, and
-192 and down-regulation of tumor suppressor miR-375. Acidic bile also
affects tumor suppressorsmiR-34a and -451a.Our findings are consistent
with recent studies suggesting miR-21, miR-375, and miR-34a as risk
factors of laryngeal carcinoma [20,24] and miR-451a as an important
biomarker in hypopharyngeal carcinogenesis, linked to GDF [30], in
accordance with Hu et al, who recently demonstrated miR-21/miR-375
ratio as an independent prognostic factor in laryngeal squamous
carcinoma [21].We assert that GDF affects LM by inducing a significant
activation of NF-κB that may interact with specific miRNA molecules,
supporting further cross talk between GDF stimulus response and
tumorigenic processes.
Taken together, our data support the observation that GDF induces
NF-κB activation at both low and neutral pH, although it appears that
the differential effect at low pH (acidic bile) ismore prominent than that
at neutral pH (DCA and CDCA) at pharmacologic but nontoxic
concentrations of 10 mM. However, at the same time, it is also very
likely that DCA and CDCA at physiologic concentrations (0-282 μM)
[4]may be constitutively ineffective.With respect tomiRNA activation,
there is clear predominance at low pH (acidic bile) as opposed to neutral
pH (bile, DCA, CDCA).
Our model provides a mechanistic link and perhaps a new
dimensional appreciation supporting the clinical observation oftenassociating GERD, gastroduodenal reflux, and laryngeal neoplasia.
Although in vivo models may not always correlate with patient-related
conditions, the reduced effects of bile salts at neutral pH versus acidic
bile enable us to suggest that the lattermay be specifically injurious.One
may also suggest that pharmacologic acid reduction in the presence of
gastroduodenal reflux may at least partially impart a protective role. It is
our hope of extending this model to investigate the effects of pepsin,
alcohol, and tobacco on GDF-exposed LM and to determine the effects
of NF-κB inhibition on tumor prevention and risk reduction in control
of neoplastic recurrences.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.neo.2016.04.007.
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